Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

In what a dying Rick Smalley called the most important application from his Nobel Prize-winning discovery [of fullerines], Houston researchers are using [carbon] nanotubes heated by radio waves to kill cancer cells. In a paper posted online by the journal Cancer, a team at the University of Texas M.D. Anderson Cancer Center and Rice University reported that the technique destroyed liver cancer tumors in rabbits and caused no side effects. It is thought to hold the same potential for many other cancers. "I don't want to overstate matters — I'm the biggest skeptic in the world — given the challenges still ahead of us," Dr. Steven Curley, an M.D. Anderson surgical oncologist and the paper's senior author, said Thursday. "But my hope is that this will be a very useful tool to safely and efficiently treat a lot of types of cancer." The therapy marries two disparate disciplines: the relatively ancient field of radio waves and nanotechnology, the cutting-edge science of the ultra-small. The rabbit study found the therapy worked only when the two were used together. It works not by poisoning but by creating a localized hyperthermia — or small fever — that destroys the cancer cells' membranes, protein and even DNA. The cells then die and are carried out of the body through normal kidney functions. In the experiment recounted in Cancer, the rabbits were injected with a solution of single-walled carbon nanotubes — hollow cylinders of pure carbon measuring about a billionth of a meter across — then exposed to two minutes of radio-frequency treatment. The result, researchers said, was the thermal destruction of 100 percent of the tumors. The idea was inspired by John Kanzius, an M.D. Anderson leukemia patient and retired Pennsylvania radio and television station owner. He developed a radio-frequency generator after undergoing chemotherapy and noting its effect on himself and other patients.

Note: For many hopeful new developments in the search for cancer cures, click here.

The nation is at risk if FDA science is at risk. In recognition of this threat, in December 2006, FDA Commissioner Andrew von Eschenbach, MD requested that the Science Board, which is the Advisory Board to the Commissioner, form a Subcommittee to assess whether science and technology at the FDA can support current and future regulatory needs. This report is the product of that assessment. The Subcommittee concluded that science at the FDA is in a precarious position: the Agency suffers from serious scientific deficiencies and is not positioned to meet current or emerging regulatory responsibilities. The FDA cannot fulfill its mission because its scientific base has eroded and its scientific organizational structure is weak. The FDA cannot fulfill its mission because its scientific workforce does not have sufficient capacity and capability. FDA does not have the capacity to ensure the safety of food for the nation. The FDA science agenda lacks a structure and vision, as well as effective coordination. The FDA has an inadequate and ineffective program for scientist performance. Recommendations of excellent FDA reviews are seldom followed.

Note: The above excerpts are all taken from the chapter headings in the initial table of contents and the second page of the initial overview.

Pharmaceutical ingredients exported from China are often made by chemical companies that are neither certified nor inspected by Chinese drug regulators, The New York Times has found. Because the chemical companies are not required to meet even minimal drug-manufacturing standards, there is little to stop them from exporting unapproved, adulterated or counterfeit ingredients. The substandard formulations made from those ingredients often end up in pharmacies in developing countries and for sale on the Internet, where more Americans are turning for cheap medicine. [At a pharmaceutical trade show in Milan], the Times identified at least 82 Chinese chemical companies that said they made and exported pharmaceutical ingredients — yet not one was certified by the State Food and Drug Administration in China, records show. Nonetheless, the companies were negotiating deals at the pharmaceutical show, where suppliers wooed customers with live music, wine and vibrating chairs. In China, chemical manufacturers that sell drug ingredients fall into a regulatory hole. Pharmaceutical companies are regulated by the food and drug agency. Chemical companies that make products as varied as fertilizer and industrial solvents are overseen by other agencies. The problem arises when chemical companies cross over into drug ingredients. “We have never investigated a chemical company,” said Ms. Yan [Jiangying], deputy director of policy and regulation at the State Food and Drug Administration. “We don’t have jurisdiction.” China has an estimated 80,000 chemical companies, and the United States Food and Drug Administration does not know how many sell ingredients used in drugs consumed by Americans. The Times examined thousands of companies selling products on major business-to-business Internet trading sites and found more than 1,300 [Chinese] chemical companies offering pharmaceutical ingredients.

Note: For many other reliable reports concerning health, click here.

Our war on microbes has toughened them. Now, new science tells us we should embrace bacteria. Any part of your body that comes into contact with the outside world ... is home to bacteria, fungi and protozoa. There are thousands of different species ... says Stanford biologist David Relman, who is investigating the complex web of interactions microbes maintain with our digestive, immune and nervous systems. Relman is a leader in rethinking our relationship to bacteria, which for most of the last century was dominated by the paradigm of Total Warfare. He says, "people still think the only good microbe is a dead one." The body's natural microbial flora aren't just an incidental fact of our biology, but crucial components of our health. Our microbes ... regulate our immune systems and even our serotonin levels: germs, it seems, can make us happy. What we need is more exposure to the good microbes. "Modern sanitation is a good thing, and pavement is a good thing," says [science writer Jessica] Sachs, "but they keep kids at a distance from microbes." The effect is to tip the immune system in the direction of overreaction, either to outside stimuli or even to the body's own cells. If the former, the result is allergies or asthma. Sachs writes that "children who receive antibiotics in the first year of life have more than double the rate of allergies and asthma in later childhood." But if the immune system turns on the body itself, you see irritable bowel syndrome, lupus or multiple sclerosis, among the many autoimmune diseases that were virtually unknown to our ancestors but are increasingly common in the developed world.

Note: For many powerful articles on health from reliable sources, click here.

Every year, malnutrition kills five million children -- that's one child every six seconds. But now, the Nobel Prize-winning relief group "Doctors Without Borders" says it finally has something that can save millions of these children. It's cheap, easy to make and even easier to use. What is this miraculous cure? It's a ready-to-eat, vitamin-enriched concoction called "Plumpynut," an unusual name for a food that may just be the most important advance ever to cure and prevent malnutrition. "It's a revolution in nutritional affairs," says Dr. Milton Tectonidis, the chief nutritionist for Doctors Without Borders. "Now we have something. It is like an essential medicine. In three weeks, we can cure a kid that ... looked like they're half dead. It’s just, boom! It's a spectacular response," Dr. Tectonidis says. No kids need it more than ... in Niger, a desperately poor country in West Africa, where child malnutrition is so widespread that most mothers have watched at least one of their children die. Why are so many kids dying? Because they can't get the milk, vitamins and minerals their young bodies need. Mothers in these villages can't produce enough milk themselves and can't afford to buy it. Even if they could, they can't store it -- there’s no electricity, so no refrigeration. Powdered milk is useless because most villagers don't have clean water. Plumpynut was designed to overcome all these obstacles. Plumpynut is a remarkably simple concoction: it is basically made of peanut butter, powdered milk, powdered sugar, and enriched with vitamins and minerals. It tastes like a peanut butter paste. It is very sweet, and because of that kids cannot get enough of it. The formula was developed by a nutritionist. It doesn't need refrigeration, water, or cooking; mothers simply squeeze out the paste. Many children can even feed themselves. Each serving is the equivalent of a glass of milk and a multivitamin.

Sunbathing, considered risky by skin cancer experts, may actually reduce the risk of breast and other cancers, new research has found. Some women who had higher sun exposure had their risk of advanced breast cancer reduced by almost half, according to the scientific study. The researchers from Stanford University, who report their findings in the American Journal of Epidemiology this week, said: "This study supports the idea that sunlight exposure reduces risk of advanced breast cancer among women with light skin pigmentation." The Stanford cancer specialists measured 4,000 women aged 35 to 79, half of them diagnosed with breast cancer, for the effects of long-term sun exposure. Sun exposure may also protect against a number of other cancers, according to a second research team who studied more than four million people in 11 countries, including 416,000 who had been diagnosed with skin cancer. These results, reported in the European Journal of Cancer, show that the risk of internal cancers ... was lower among people living in sunny countries. The researchers said: "Vitamin D production in the skin seems to decrease the risk of several solid cancers, especially stomach, colo-rectal, liver and gall- bladder, pancreas, lung, female breast, prostate, bladder and kidney cancers." Sunlight plays a vital role in the production of beneficial vitamin D in the body. Although food provides some vitamin D, up to 90 per cent comes from exposure to sunlight.

Note: For many reliable, verifiable reports on promising cancer cures, click here.

The medicines long used by parents to treat their children's coughs and colds don't work and shouldn't be used in those younger than 6, federal health advisers recommended. "The data that we have now is they don't seem to work," said Sean Hennessy, a University of Pennsylvania epidemiologist. The recommendation applies to medicines containing one or more of the following ingredients: decongestants, antihistamines and antitussives. In two separate votes ... the panelists said the medicines shouldn't be used in children younger than 2 or in those younger than 6. A third vote, to recommend against use in children 6 to 11, failed. The panel's advice dovetails with a petition filed by pediatricians that argued the over-the-counter medicines shouldn't be given to children younger than 6, an age group they called the most vulnerable to potential ill effects. The American Academy of Pediatrics and other groups back the petition. But FDA officials and panelists agreed there's no evidence they work in older children, either. Still, panelists held off from recommending against use in those 6 and older. And some said they feared such a prohibition wouldn't eliminate use of the medicines by parents. "They will administer adult products to their children because they work for them or feel they work for them," said the panel's patient and family representative, Amy Celento of Nutley, N.J. Some of the drugs — which include Wyeth's Dimetapp and Robitussin, Johnson & Johnson's Pediacare and Novartis AG's Triaminic products — have never been tested in children, something flagged as long ago as 1972 by a previous FDA panel. An FDA review found just 11 studies of children published over the last half-century. Those studies did not establish that the medicines worked in those cases, according to the agency.

Note: For a powerful exposé of corporate and government corruption in the health industry, click here.

More than half of department chairs at U.S. medical schools and teaching hospitals have financial ties with the drug industry, a new study finds. "There is not a single aspect of medicine in which the drug companies do not have substantial and deep relationships, [including] doctors-in-training, resident physicians, researchers, physicians-in-practice, the people who review drugs for the federal government and the people who review studies," said lead researcher Eric Campbell, associate professor at the Institute for Health Policy at Massachusetts General Hospital and Harvard Medical School in Boston. "Drug companies have relationships with everyone," he continued. "They're involved in every aspect of medicine. Someone has to decide which of these is OK." The study, the first to examine the extent of these institutional relationships, is published in the Oct. 17 issue of the Journal of the American Medical Association. "I think the paper is a very valuable contribution, in that it provides what's probably the first comprehensive documentation of the extent of relationships that involve department chairs, and department chairs are certainly the key agents of overseeing and maintaining the day-to-day operations of a medical school or teaching hospital," said Dr. David Korn ... at the Association of American Medical Colleges in Washington, D.C. The issue of medicine's ties to industry has been a hot one of late. One study found that third-year medical students get, on average, one gift or attend one activity sponsored by a drug maker each week. "Now it's up to the policymakers and people who run medical schools," said Campbell. "They need to come up with some rules and they need to be new rules. I believe there's very little reasonable justification for why drug companies should be involved in the education of medical students."

Note: For a powerful overview of medical corruption, click here.

Using a mobile phone for more than 10 years increases the risk of getting brain cancer, according to the most comprehensive study of the risks yet published. The study – which contradicts official pronouncements that there is no danger of getting the disease – found that people who have had the phones for a decade or more are twice as likely to get a malignant tumour on the side of the brain where they hold the handset. The scientists who conducted the research say using a mobile for just an hour every working day during that period is enough to increase the risk – and that the international standard used to protect users from the radiation emitted is "not safe" and "needs to be revised". They conclude that "caution is needed in the use of mobile phones" and believe children, who are especially vulnerable, should be discouraged from using them at all. Official assurances that the phones are safe have been based on research that has, at best, included only a few people who have been exposed to the radiation for long enough to get the disease, and are therefore of little or no value in assessing the real risk. The scientists pulled together the results of the 11 studies that have so far investigated the occurrence of tumours in people who have used phones for more than a decade, drawing on research in Sweden, Denmark Finland, Japan, Germany, the United States and Britain. They found almost all had discovered an increased risk, especially on the side of the head where people listened to their handsets. [One of the study's authors] said he uses a mobile phone as little as possible, and urges others to use hands-free equipment and make only short calls, reserving longer ones for landlines. He also said that mobiles should not be given to children, whose thinner skulls and developing nervous systems make them particularly vulnerable.

Note: Evidence has been mounting for some years that cell phones and wireless technology (WiFi) have significant health risks. For a recent brief summary by a highly respected scientist, click here.

More than 14 months after the Agriculture Department began an investigation into how the U.S. supply of long-grain rice became tainted with an unapproved genetically engineered variety -- an event that continues to disrupt U.S. exports -- the government announced yesterday that it could not figure out how the contamination happened. Agency officials said documents from several years ago that might have helped them determine what went wrong had been lost or destroyed. Lacking clear evidence of who was responsible, they said, the government will not take enforcement action against any person or entity, including Bayer CropScience, the company whose gene-altered products slipped into the food supply. The widespread, low-level contamination with experimental genes that make the rice pesticide-tolerant, one of several such events in recent years, prompted countries around the world to cut off imports of U.S. long-grain rice. Rice prices plummeted, and many farmers, scientists and biotechnology activists called for an overhaul of the oversight system for gene-altered crops. While some countries have begun to accept U.S. rice with added testing, the European Union and Russia have not -- a trade loss valued in the hundreds of millions of dollars a year. Critics assailed the report as yet more evidence that the nation's regulatory system for gene-altered crops is broken. "This underlines the anxiety people have about more such incidents occurring," said Margaret Mellon of the Union of Concerned Scientists, a science-based advocacy group that has called for a more rigorous approval process for biotech crops.

Note: For important reports from major media sources which reveal the dangers of genetically modified foods and other organisms, click here.

Despite the protests of more than 50 scientists, including five Nobel laureates in chemistry, the U.S. Environmental Protection Agency on Friday approved use of a new, highly toxic fumigant, mainly for strawberry fields. The new pesticide, methyl iodide, is designed for growers, mainly in California and Florida, who need to replace methyl bromide, which has been banned under an international treaty because it damages the Earth's ozone layer. In a letter sent last month to EPA Administrator Stephen Johnson, 54 scientists, mostly chemists, warned that "pregnant women and the fetus, children, the elderly, farmworkers and other people living near application sites would be at serious risk." Methyl iodide is a neurotoxin and carcinogen that has caused thyroid tumors, neurological damage and miscarriages in lab animals. But EPA officials said Friday that they carefully evaluated the risks and decided to approve its use for one year, imposing restrictions such as buffer zones to protect farmworkers and neighbors. Growers, particularly those who grow strawberries and tomatoes, have been searching for 15 years for a new soil fumigant to replace methyl bromide. Fumigants are valuable to growers because they can be injected into the soil before planting to sterilize the field and kill a broad spectrum of insects and diseases without leaving residue on crops. But fumigants are among the most potentially dangerous pesticides in use today because the toxic gas can evaporate from the soil, exposing farmworkers and drifting into neighborhoods. Methyl iodide ... will be allowed on fields growing strawberries, tomatoes, peppers, ornamentals, turf, trees and vines.

If someone had asked Kelly Pless to describe herself three years ago, the word "fit" would have never crossed her mind. For most of her adult life, the 31-year-old ... has struggled with her weight. She started gaining as a teenager and by the time she graduated from high school, she was carrying 215 pounds on her 5' 2" frame. At 28, she started having trouble breathing and doctors told her the weight was to blame. She reached her breaking point. Pless decided to do something. Fortunately she didn't have to look far for inspiration. "My manager at the Kennedy Space Center ran marathons, and he was the same age as my father," she said. Over the next three to four months, she began walking, without any real goal or expectation. Pless believed that if she just focused on eating less and moving more, everything would fall into place. "At first, it was hard to start exercising because I was worried people would make fun of me," Pless said. "But then I just told myself, if that's the worst that could happen ... I just got out there and didn't care." She also adopted an "eat to live" philosophy and satisfied her cravings for sweets by eating lots of fruit. "After a few months of cutting [snacks and sweets] out, I focused more on portion control," said Pless. "I pretty much eat when I'm hungry and don't eat when I'm not and really try to pay attention to when those times are. Pless asks herself, "What do I really want to eat? Or, what does my body really want right now?" All of the hard work and determination paid off. Pless has lost 95 pounds and kept it off for 1˝ years. As a result, she says, she's healthier and more confident. Pless runs about 40 miles a week while she trains for two marathons she plans to run this winter. "Running has become a constant for me and does so much more for me than maintain my weight, which is now about 125 pounds," said Pless.

Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. The civil settlement ... resolves a broad array of allegations against Bristol-Myers Squibb, dating from 1994 through 2005. Among them was a charge that the ... company illegally promoted the sale of Abilify, an anti-psychotic drug, for pediatric use and to treat dementia-related psychoses. Neither use is approved by the U.S. [FDA]. Although physicians are permitted to prescribe drugs for off-label uses, drug companies are prohibited from marketing them for uses that have not been approved by the FDA. U.S. Attorney Michael Sullivan said when pharmaceutical companies market drugs for unapproved uses, there is a potential risk that patients could be harmed, because the drugs have not been tested as rigorously as they are during the FDA approval process. The government also alleged the company paid illegal inducements in the form of consulting fees and trips to luxury resorts to influence doctors and other health care providers to buy and prescribe the company's drugs. The company's former generic drug subsidiary, Apothecon Inc., also was accused of giving illegal enticements to induce retail pharmacy and wholesale customers to buy its products. Bristol-Myers Squibb misreported its best price for the anti-depression drug Serzone, violating a law that requires drug companies to report their lowest price to Medicaid, prosecutors said. The company was selling Serzone to a larger commercial purchaser at a lower price, prosecutors said. Bristol-Myers Squibb and Apothecon also inflated prices for an assortment of oncology and generic drugs knowing that federal health care programs established reimbursement rates based on those prices, Sullivan said.

Note: For lots more on corporate corruption, click here.

The Food and Drug Administration does very little to ensure the safety of the millions of people who participate in clinical trials, a federal investigator has found. The inspector general of the Department of Health and Human Services, Daniel R. Levinson, said federal health officials did not know how many clinical trials were being conducted, audited fewer than 1 percent of the testing sites and, on the rare occasions when inspectors did appear, generally showed up long after the tests had been completed. The F.D.A. has 200 inspectors, some of whom audit clinical trials part time, to police an estimated 350,000 testing sites. Even when those inspectors found serious problems in human trials, top drug officials in Washington downgraded their findings 68 percent of the time, the report found. Among the remaining cases, the agency almost never followed up with inspections to determine whether the corrective actions that the agency demanded had occurred. “In many ways, rats and mice get greater protection as research subjects in the United States than do humans,” said Arthur L. Caplan, chairman of the department of medical ethics at the University of Pennsylvania. Animal research centers have to register with the federal government, keep track of subject numbers, have unannounced spot inspections and address problems speedily or risk closing, none of which is true in human research, Mr. Caplan said. Because no one collects the data systematically, there is no way to tell how safe the nation’s clinical research is or ever has been. The drug agency oversees just the safety of trials by companies seeking approval to sell drugs or devices. Using an entirely different set of rules, the Office for Human Research Protections oversees trials financed by the federal government. Privately financed noncommercial trials have no federal oversight.

Note: For further information on corruption in the health care industry, click here.

When the U.S. Food and Drug Administration approved implanting microchips in humans, the manufacturer said it would save lives, letting doctors scan the tiny transponders to access patients' medical records almost instantly. The FDA found "reasonable assurance" the device was safe, and a sub-agency even called it one of 2005's top "innovative technologies." But neither the company nor the regulators publicly mentioned this: A series of veterinary and toxicology studies, dating to the mid-1990s, stated that chip implants had "induced" malignant tumors in some lab mice and rats. "The transponders were the cause of the tumors," said Keith Johnson, a retired toxicologic pathologist, explaining ... the findings of a 1996 study he led at the Dow Chemical Co. Leading cancer specialists reviewed the research for The Associated Press and ... said the findings troubled them. Some said they would not allow family members to receive implants, and all urged further research before the glass-encased transponders are widely implanted in people. To date, about 2,000 of the so-called radio frequency identification, or RFID, devices have been implanted in humans worldwide. Did the agency know of the tumor findings before approving the chip implants? The FDA declined repeated AP requests to specify what studies it reviewed. The FDA is overseen by the Department of Health and Human Services, which, at the time of VeriChip's approval, was headed by Tommy Thompson. Two weeks after the device's approval took effect on Jan. 10, 2005, Thompson left his Cabinet post, and within five months was a board member of VeriChip Corp. and Applied Digital Solutions. He was compensated in cash and stock options.

Note: For more reliable information about the use and dangers of microchips, click here.

Ten days ago, the Consumer Product Safety Commission announced another in a series of well-publicized recalls of Chinese-made goods: children's art sets containing crayons, markers, pastels, pencils, water colors -- and lead -- distributed by Toys "R" Us. "Consumers should immediately take the products away from children," warned a news release from the federal government's watchdog for thousands of household items. "The CPSC is committed to protecting consumers and families." But 13 months earlier, in July 2006, the CPSC ... authorized a Los Angeles company to export to Venezuela 16,520 art sets that violated the same CPSC standard protecting children from dangerous art supplies. The following month, the agency authorized a Miami company to export to Jamaica 5,184 sets of wax crayons that also violated the standard. For decades the federal agency has allowed American-based companies to export products deemed unsafe here. Those products can present an even greater danger in a country that has only a handful of government employees devoted to consumer protection, said R. David Pittle, a former acting CPSC chairman who spent 22 years as a senior vice president for Consumers Union. "If the United States doesn't have very many inspectors, how many do you think there are in Honduras or Jamaica or Trinidad or Bulgaria?" Pittle asked. Using the CPSC's database of exports of non-approved products and hundreds of pages of documents obtained through the federal Freedom of Information Act, The Bee found that between October 1993 and September 2006, the CPSC received 1,031 requests from companies to export products the agency had found unsafe for American consumers. The CPSC approved 991 of those requests, or 96 percent.

More than 260 doctors from around the world have launched an unprecedented attack on the American medical establishment for its failure to condemn unethical practices by medical practitioners at the Guantanamo Bay prison camp in Cuba. In a letter to The Lancet, the doctors from 16 countries, including Britain and America, say the failure of the US regulatory authorities to act is "damaging the reputation of US military medicine". They compare the actions of the military doctors, whom they accuse of being involved in the force-feeding of prisoners at Guantanamo Bay and of turning a blind eye to evidence of torture in Iraq and elsewhere, to those of the South African security police involved in the death of the anti-apartheid activist Steve Biko 30 years ago. The group highlighted the force-feeding of prisoners at Guantanamo Bay last year and suggested the physicians involved should be referred to their professional bodies for breaching internationally accepted ethical guidelines. The doctors wrote: "No healthcare worker in the War on Terror has been charged or convicted of any significant offence despite numerous instances documented including fraudulent record-keeping on detainees who have died as a result of failed interrogations ... The attitude of the US military establishment appears to be one of 'See no evil, hear no evil, speak no evil'." The US introduced the policy of force-feeding, in which prisoners are strapped to a chair and a tube is forced down the throat into the stomach, after more than 100 prisoners went on hunger strike in 2005. "Fundamental to doctors' responsibilities in attending a hunger striker is the recognition that prisoners have a right to refuse treatment," the doctors wrote.

In an attempt to raise the nation's historically low rate of breast-feeding, federal health officials commissioned an attention-grabbing advertising campaign a few years ago to convince mothers that their babies faced real health risks if they did not breast-feed. It featured striking photos of insulin syringes and asthma inhalers topped with rubber nipples. Plans to run these blunt ads infuriated the politically powerful infant formula industry, which hired a former chairman of the Republican National Committee and a former top regulatory official to lobby the Health and Human Services Department. Not long afterward, department political appointees toned down the campaign. The ads ran instead with more friendly images of dandelions and cherry-topped ice cream scoops, to dramatize how breast-feeding could help avert respiratory problems and obesity. In a February 2004 letter (pdf), the lobbyists told then-HHS Secretary Tommy G. Thompson they were "grateful" for his staff's intervention to stop health officials from "scaring expectant mothers into breast-feeding," and asked for help in scaling back more of the ads. The formula industry's intervention -- which did not block the ads but helped change their content -- is being scrutinized by Congress in the wake of last month's testimony by former surgeon general Richard H. Carmona that the Bush administration repeatedly allowed political considerations to interfere with his efforts to promote public health. "This is a credible allegation of political interference that [may] have had serious public health consequences," said [Rep. Henry] Waxman, a California Democrat. The milder campaign HHS eventually used had no discernible impact on the nation's breast-feeding rate, which lags behind the rate in many European countries.

When patients feel they might be having an adverse drug effect, doctors will very often dismiss their concerns, a new study shows. In a survey of 650 patients taking cholesterol-lowering drugs called statins, who reported having adverse drug reactions, many said their physicians denied that the drug could be connected to their symptoms, Dr. Beatrice A. Golomb of the University of California at San Diego ... found. “Physicians seem to commonly dismiss the possibility of a connection,” Golomb [said]. “This seems to occur even for the best-supported adverse effects of the most widely prescribed class of drugs. Clearly there is a need for better physician education about adverse effects, and there is a strong need for patient involvement in adverse event reporting.” The best-known side effects of statins ... are liver damage and muscle problems, although statins have also been tied to changes in memory, concentration and mood. Physician reaction to a potential side effect is crucial because the muscle problems can progress to a rare but potentially fatal condition called rhabdomyolysis if the drug isn’t discontinued. The researchers investigated the response of doctors to statin patients who believed they were having adverse drug reactions. In the great majority of cases, the patient, not the doctor, initiated the discussion. Forty-seven percent of patients with muscle problems or cognitive problems said their doctors dismissed the possibility that their symptoms were statin-related, while 51 percent of patients with peripheral neuropathy, a type of nerve pain affecting the extremities, said their doctors denied a possible connection with statins.

Note: For a hard-hitting overview of medical corruption, click here.

The US government is on a ‘burning platform’ of unsustainable policies and practices with fiscal deficits, chronic healthcare underfunding, immigration and overseas military commitments threatening a crisis if action is not taken soon, the country’s top government inspector has warned. David Walker, comptroller general of the US, issued the unusually downbeat assessment of his country’s future in a report that lays out what he called “chilling long-term simulations”. These include “dramatic” tax rises, slashed government services and the large-scale dumping by foreign governments of holdings of US debt. Drawing parallels with the end of the Roman empire, Mr Walker warned there were “striking similarities” between America’s current situation and the factors that brought down Rome, including “declining moral values and political civility at home, an over-confident and over-extended military in foreign lands and fiscal irresponsibility by the central government. In my view, it’s time to learn from history.” Mr Walker’s views carry weight because he is a non-partisan figure in charge of the Government Accountability Office, often described as the investigative arm of the US Congress. In an interview with the Financial Times, Mr Walker said he had mentioned some of the issues before but now wanted to “turn up the volume”. Some of them were too sensitive for others in government to “have their name associated with. I’m trying to sound an alarm and issue a wake-up call,” he said. “As comptroller general I’ve got an ability to look longer-range and take on issues that others may be hesitant, and in many cases may not be in a position, to take on."

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.